This is a $348,666.65 delivery order awarded by the Medical Command (MEDCOM) of the U.S. Army to Leidos, Inc. for scientific and administrative support services. The contract is a time and materials arrangement with an ultimate completion date of October 30, 2016. Leidos will provide these services through its Leidos Services Operating Segment, which also does business as SAIC. The contract is not designated as a set-aside. This award positions Leidos as a key partner supporting critical medical...
This federal contract award is for FY18/19 JPC-1/MSISRP SUPPORT, provided by the U.S. Army Medical Command (MEDCOM) to prime contractor Leidos, Inc. The $108,104.69 cost-plus-fixed-fee delivery order has a completion date of January 31, 2019. Leidos operates through its Leidos Services Operating Segment division, also doing business as SAIC. This contract supports medical research programs, including studies on traumatic brain injury, psychological health, cancer, and rare diseases, for the...
This is a delivery order contract awarded by the Medical Command (MEDCOM) component of the U.S. Army to Leidos, Inc. The contract has a ceiling value of $1,857,361.86 and a period of performance ending on March 5, 2023. The contract is for FY 18/19 support to the Joint Program Committee-8/Congressionally Directed Medical Research Programs (JPC-8/CRMRP). This contract is a cost-plus-fixed-fee type and does not have a set-aside designation. Leidos, Inc. is the prime contractor, and the award...
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Leidos, Inc. for military medical research and development services. The contract has a ceiling value of $2,500.00 and a completion date of June 19, 2023. Leidos, a global leader in IT, engineering, and science solutions, is providing these services through its Leidos Services Operating Segment division. The contract does not have a set-aside designation. Leidos has previously received various prime and...
This is a federal contract award to Leidos, Inc. by the U.S. Army Medical Command (MEDCOM) for the Bone Marrow Failure Research Program (BMFRP) under the Congressionally Directed Medical Research Programs (CDMRP). The contract, valued at $376,777.73, is a Delivery Order with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of April 30, 2023. The contract does not have a set-aside designation. Leidos, Inc. is a large, global technology and engineering solutions provider that...
This is a $413,697.84 Cost Plus Fixed Fee delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Leidos, Inc. The contract is under the Medical Product Research and Development indefinite delivery vehicle (IDV) and is for a Repeat Dose Toxicity Study. Leidos has subcontracted a portion of the work to SNBL U.S.A., LTD. The contract does not have a set-aside designation. This award supports MEDCOM's medical research programs, which encompass efforts related to traumatic brain...
This is a $146,336.80 delivery order contract awarded by the Department of the Army Medical Command to Leidos, Inc. The contract provides support services for the FY 18 MSISRP/JPC-1 (CDMRP) program, which is a medical research initiative managed by the Army's Congressionally Directed Medical Research Programs. The contract was awarded on a cost-plus-fixed-fee basis with a completion date of September 16, 2019. The work is being performed at Fort Detrick, MD. Leidos, Inc. is a global technology...
This is a Delivery Order contract awarded by the Department of the Army Medical Command to Leidos, Inc. The contract provides support for the FY 18 JPC-6 DMRDP PHTBI program, which likely involves medical research and development work. The contract has a potential value of $114,954.46 and a completion date of June 14, 2019. It is a Cost Plus Fixed Fee contract, indicating the government is reimbursing the contractor's allowable costs plus a fixed fee. There is no set-aside designation...
This is a delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for fiscal year 2023 general medical research and development command and joint program committees support. The $255,432.22 cost-plus-fixed-fee contract has an ultimate completion date of August 25, 2024. It was not set aside for any specific business category. Leidos, a global technology and engineering solutions provider, will deliver comprehensive medical research program support for the Defense Health...
This federal contract award, W81XWH17D0025|W81XWH22F0223, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense for the Fiscal Year 2022 Defense Medical Research and Development Program (FY22 DMDRP). The $99,864.13 Cost Plus Fixed Fee delivery order was awarded to Leidos, Inc., a global technology and engineering solutions provider, through its Leidos Services Operating Segment division. The contract does not have a set-aside designation. The award supports medical...
This is a cost-plus-fixed-fee delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Leidos, Inc. under the Medical Product Research and Development indefinite delivery/indefinite quantity (IDIQ) contract. The $231,472.98 contract is for market research and analysis of alternatives regarding cold stored platelets in platelet additive solution (CSP-PAS). The effort supports the Defense Health Agency and medical research programs. The contract does not have a set-aside designation.